Mizuho lowers Westlake Chemical stock price target to $82 from $100

Mizuho analysts reduced their price target for Westlake Chemical (WLK) to $82 from $100, maintaining an Outperform rating, citing challenges in polyethylene pricing and lower export volumes to China due to tariff uncertainties; this revision reflects lowered EBITDA estimates through 2027. The adjustment aligns with similar price target reductions from Truist, UBS, and Citi, all acknowledging near-term headwinds in the commodity chemicals sector, particularly in polyethylene and PVC markets, despite Westlake's strong financial position and competitive advantages in PVC and caustic soda.

Analysis

Mizuho analysts have adjusted their outlook for Westlake Chemical (NYSE:WLK), reducing the price target to $82 from $100 while notably maintaining an Outperform rating. This revision occurs with WLK trading at $71.03 and is primarily driven by challenges polyethylene producers face in raising prices, evidenced by flat contract prices in March followed by a $0.03 per pound decrease in April, compounded by lower export volumes to China due to tariff uncertainties. Consequently, Westlake's EBITDA estimates have been significantly lowered: the second-quarter forecast is now $367 million (down from $420 million), the 2025 estimate is $1.4 billion (from $1.9 billion), and the 2026 and 2027 estimates are reduced to $1.8 billion and $2.0 billion respectively (from $2.4 billion and $2.7 billion). This cautious stance is shared across Wall Street, with Truist Securities lowering its target to $92, UBS to $101, Citi to $85, and BMO Capital Markets to $94, all citing near-term headwinds in commodity chemicals, particularly in Polyethylene (PE), Polyvinyl Chloride (PVC), and Polyethylene Monomer (PEM) segments, as well as a subdued renovation market. Despite these multiple downward revisions and an overall 'moderately negative' sentiment score of -0.45 (WLK specific sentiment at -0.4), InvestingPro analysis suggests the stock is undervalued and assigns it a 'FAIR' financial health score. Analysts also acknowledge Westlake's $9.1 billion market cap, $12 billion annual revenue, competitive advantages in PVC and caustic soda, and a solid financial position. Recent shareholder approvals regarding board members and auditors underscore a commitment to corporate governance.

Key Decisions for Investors

• Investors should closely monitor polyethylene and PVC pricing dynamics, alongside export demand, particularly from China, as these are pivotal to Westlake Chemical's revised and lowered earnings trajectory.
• Despite multiple price target reductions reflecting near-term sector challenges, the persistence of 'Outperform' or 'Buy' ratings and InvestingPro's 'undervalued' assessment may present a consideration for long-term investors, but this must be carefully weighed against the substantial downward revisions in EBITDA forecasts and ongoing tariff-related risks.
• Evaluate Westlake's 'FAIR' financial health score and recognized competitive strengths in PVC and caustic soda as potential buffers when assessing the impact of current market adversities on investment theses and position sizing.